Excellence in Pediatrics Institute

Vaccines may be free for everyone, but that does not mean everyone has the same chance of being vaccinated. In this briefing from the 10th LifeCourse Prevention Summit, Michael Edelstein examines how system-level failures continue to drive immunization inequities, even in countries with high overall vaccine coverage. The discussion explores the difference between equality and equity in immunization, why vaccine uptake alone can hide important gaps in timeliness and completion, and how underserved communities often face very different barriers within the same health system. The briefing highlights the importance of culturally aware services, community trust, tailored approaches, and better data to truly understand and address vaccination inequities. Watch the full briefing below. #Vaccination #Immunization #HealthEquity #PublicHealth #RSV #LifeCoursePrevention 

Communities are not "hard to reach" when health systems are willing to meet people where they are. In this interview, conducted by Colin Michie and Professor Monica Lakhanpaul during the 10th LifeCourse Prevention Summit, Professor Angela Harden reflects on why public health interventions are often less effective when communities are not involved in shaping them. The conversation explores the importance of lived experience, shared decision-making, and creating prevention strategies with communities rather than for communities, particularly when it comes to vaccination, trust and health inequalities. A thoughtful discussion on moving public health from reactive models of care toward meaningful community partnership. Watch the full interview below. #Vaccination #Immunization #CommunityEngagement #HealthEquity #PublicHealth #LifeCoursePrevention

The EiP report on RSV Prevention, developed from the 17th Excellence in Pediatrics Conference and the 10th LifeCourse Prevention Summit, examines the evidence for RSV prevention in the first years of life and sets out clear recommendations for clinicians, health system leaders and policymakers. From the burden of disease and the case for universal protection strategies to real-world effectiveness data, global equity, and the life-course framing, it brings together science, policy, and the lived experiences of affected families. Read or Download the full report below. #RSV #RSVPrevention #ChildHealth #VaccinePolicy #LifeCoursePrevention #InfantHealth #PublicHealth

One country figured out how to protect 92.5% of its infants against RSV. The answer was not choosing between maternal vaccination and monoclonal antibodies, but it was using both. In this briefing from the 10th LifeCourse Prevention Summit, Prof. Susanna Esposito presents the evidence on RSV immunization strategies across Europe and beyond, and makes the case for adapting prevention approaches to each country's context while never losing sight of the goal: all infants need protection. Watch the full briefing here: https://lnkd.in/dVcfa4Ma The Luxembourg model shows what a combined strategy can achieve. Moving from monoclonal antibodies alone to a combined approach increased coverage from 81% to 92.5% and reduced RSV hospitalizations by 76%. The tools exist. The question is how to use them together. Featured also in the upcoming EiP RSV Prevention Newsletter. #RSV #RSVPrevention #PediatricHealth #Immunization #ChildHealth #LifeCoursePrevention

To stop RSV, healthcare professionals need to become the "super spreaders" of prevention. That is the call Prof. Roy K Philip makes in this interview from the 10th LifeCourse Prevention Summit. RSV does not begin in the hospital. It travels through communities, from toddlers to newborns to grandparents, in what he describes as the RSV March. And the tools to interrupt it already exist: maternal vaccination, newborn immunization and exclusive breastfeeding. The Irish Pathfinder program showed what is possible: 90% uptake of newborn immunization across all Irish maternity hospitals, reducing pediatric ward admissions by up to 74%. The question now is whether these prevention strategies can be scaled to low and middle-income countries, where RSV is the second leading cause of mortality in young children. Watch the interview, featured in the EiP RSV Campaign. #RSV #PediatricHealth #Immunization #LifeCoursePrevention #ChildHealth #RSVPrevention

LifeCourse Prevention Initiative (LIFE) | Vaccination Equity

We are looking forward to welcoming you to Copenhagen for the 18th Excellence in Pediatrics Conference (EIP2026), taking place 3–5 December 2026. Registration and abstract submission are now open. #EIP2026 #Pediatrics #ChildHealth #MedicalEducation #Copenhagen

The EiP report on Immunization and Vaccination Equity, developed from the December 2025 LifeCourse Prevention Summit, examines why significant inequities in vaccination uptake persist across populations and sets out concrete actions to address them. From data blind spots and structural barriers to trust, community engagement, and policy reform, the report brings together evidence and perspectives from across public health, clinical practice, social science, and civil society. Download the full report below. #VaccinationEquity #Immunization #LifeCoursePrevention #PublicHealth #ChildHealth